Cite
HARVARD Citation
Eremeeva, A. et al. (n.d.). FRI0224 Comparison of Efficacy and Safety of Rituximab Biosimilar, BCD-020, and Innovator Rituximab in Patients with Active Rheumatoid Arthritis Refractory To TNFA Inhibitors. Annals of the rheumatic diseases. pp. 513-514. [Online].